000661 Changchun High-Tech Industries
- 113.08
- -2.01-1.75%
Changchun High-Tech Industries News
Changchun Hi-Tech: Announcement on the approval of the subsidiary\'s application for marketing of polyethylene glycol recombinant human growth hormone injections for new indications by the State Drug Administration
Changchun Hi-Tech: Announcement on completing the registration of industrial and commercial changes and issuing a business license
Changchun Hi-Tech: Announcement on the company\'s intention to invest in joint investment with professional investment institutions to establish a partnership
Changchun Hi-Tech: Announcement on the subsidiary\'s application for adding new specifications for injectable human growth hormone approved by the State Drug Administration
Changchun Hi-Tech: Announcement on the subsidiary GenSci 122 tablet project obtaining implied approval from the US Food and Drug Administration to apply for clinical trials of new drugs
Changchun Hi-Tech: Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders
Changchun Hi-Tech: Legal Opinion of Beijing Dacheng (Changchun) Law Firm on the 2024 Fourth Extraordinary General Meeting of Shareholders of Changchun Hi-Tech Industry (Group) Co., Ltd.
Changchun Hi-Tech: Announcement on the completion of restricted stock cancellation and adjustment of targeted convertible debt-for-share prices in the 2022 Restricted Stock and Stock Option Incentive Plan
Changchun Hi-Tech: Notice on Convening the Fourth Extraordinary General Meeting of Shareholders in 2024
Changchun Hi-Tech: Announcement on Subsidiary GenSci098 Injection Obtaining Implied Approval from the US Food and Drug Administration to Apply for Clinical Trials of New Drugs
Changchun High-Tech Industries: Announcement for the approval of the launch application for new specifications and indications of recombinant human growth hormone injection of Polyethylene Glycol (PEG) subsidiary.
Changchun High-Tech Industries: Announcement about Subsidiary's External Guarantees
Changchun High-Tech Industries: Financial Report for the first half of 2024.
Changchun High-Tech Industries: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Changchun High-Tech Industries: Announcement on the Reduction of Restricted Stocks for Buyback and Cancellation and the Notification of Creditors Regarding the Reduction of Registered Capital.
Changchun High-Tech Industries: Announcement of the resolution of the third interim shareholders meeting in 2024.
Changchun High-Tech Industries: Announcement on Approval of Clinical Trial Application for GenSci098 Injection of Subsidiary
Changchun High-Tech Industries: Company Bylaws (Revised in August 2024)
Changchun High-Tech Industries: Legal opinion of Beijing Dacheng (Changchun) Law Firm on the 3rd extraordinary general meeting of shareholders of Changchun High-tech Industries (Group) Co., Ltd. in 2024.
Changchun High-Tech Industries: Notice on convening the third extraordinary shareholder meeting in 2024.
Analysis
Price Target
No Data
No Data